Pfizer-BioNTech Vaccine
Pfizer Vaccines Are Safe & Effective for Children 5 – 11, says Study
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit “Cookie Settings” to provide a controlled consent. You Deserve to Make Money Even When you are looking for Dates Online. So we reimagined what a dating should be. It begins with giving you back power. Get to meet Beautiful people, chat and make money in the process. Earn rewards by chatting, sharing photos, blogging and help give users back their fair share of Internet revenue.
Nigeria expects 41 million coronavirus vaccine doses from African Union
Nigeria expects to receive 41 million Covid-19 vaccine doses from the African Union, the head of the country’s primary healthcare agency said on Monday, while the health minister said vaccines from Russia and India were being considered. Authorities in Africa’s most populous country, which has 200 million people, plan to inoculate 40% of the population this year and another 30% in 2022. The African Union initially secured 270 million Covid-19 vaccine doses from manufacturers for member states. Last week it was announced that the bloc would receive another 400 million doses of the AstraZeneca vaccine. Faisal Shuaib, who heads the National Primary Health Care Development Agency, said Nigeria’s previous request for 10 million doses through the AU had been increased four-fold. “We have applied...
Pfizer, BioNTech to limit delays of vaccine shipments to one week
Pfizer and BioNTech said Saturday they will limit the delays of their vaccine deliveries to just one week, after fears in Europe that shipments of the jabs could be slowed for up to a month. The US drugmaker and its German partner “have developed a plan that will allow the scale-up of manufacturing capacities in Europe and deliver significantly more doses in the second quarter,” they said in a joint statement. “As a result, our facility in Puurs, Belgium will experience a temporary reduction in the number of doses delivered in the upcoming week.” Pfizer and BioNTech pledged that deliveries would be back to the original schedule to the European Union from the week of January 25, with increased delivery from the week of February 15. “To accomplish this, certain modifications of production pr...
Coronavirus: Concern grows over potential superspreader event during US Capitol riot
Concerns are mounting about the health of lawmakers and other people in the Capitol last week, after the first member to test positive for the Coronavirus (COVID-19) since Wednesday’s chaos, said she believed she was exposed in a crowded hiding place with hundreds of other legislators. Rep. Bonnie Watson Coleman, D-N.J., tested positive on Monday while experiencing mild symptoms, and said in a statement that she believes she caught the virus from her fellow lawmakers while hunkering down as Capitol Police struggled for hours to contain a Trump-inspired mob attack on the Capitol. Lawmakers were trapped in a room near the Capitol with hundreds of others, in some cases for hours, where at least one person who later tested positive for the coronavirus was present. The Office of the Attending P...
Germany starts coronavirus vaccines a day early
A 101-year-old woman in an elderly care home became the first person in Germany to be inoculated against coronavirus on Saturday, a day before the official vaccination campaign was scheduled to get under way in both Germany and the EU. Edith Kwoizalla was one of around 40 residents and 10 staff in a care home in the eastern state of Saxony-Anhalt to receive a jab of the Pfizer-BioNTech vaccine, the home’s manager Tobias Krueger told AFP. The Pfizer-BioNTech vaccine became the first to get the go-ahead for use in the West, when Britain gave its approval on December 2. As other nations from the United States to Saudi Arabia to Singapore followed suit, Germany impatiently prodded the EU’s drugs regulator, the European Medicines Agency, to bring forward its decision from December 29. The EMA f...
Canada approves Pfizer-BioNTech coronavirus vaccine
Canadian health officials have authorised the Pfizer-BioNTech COVID-19 vaccine, hailing the development as a “critical milestone” and paving the way for the inoculant to be administered across the country. The authorisation on Wednesday comes a day after the United Kingdom became the first country to begin giving the vaccine to the public. Emergency use authorisation (EUA) is also pending in the United States, with officials saying the first doses could be administered as early as next week. The US Food and Drug Administration is scheduled to consider its EUA on Thursday. Bahrain has also authorised the vaccine for public use. “Canadians can feel confident that the review process was rigorous and that we have strong monitoring systems in place,” Health Canada, the department responsible fo...
Coronavirus vaccine breakthrough raises hopes of rapid global rollout
A coronavirus vaccine developed by Britain’s University of Oxford and the pharmaceutical firm AstraZeneca has shown successful results in early trials. If it is approved by regulators, the vaccine appears suitable for a fast rollout around the globe. Early analysis of trials involving 20,000 volunteers in Britain and Brazil show the vaccine is at least 62% effective after two doses. In volunteers given a different dosing regimen — a half dose, followed by a full dose — that figure rose to 90%. The average efficacy of the two dosing methods is 70%. None of those given the vaccine developed severe COVID-19 illness. Andrew Pollard, director of the Oxford Vaccine Group, said the recent successful trials of three different vaccines by Oxford-AstraZeneca, Pfizer-BioNTech and Moderna, represent a...
